Maryland Is Launching a Free Cannabis Care Hotline for Medical Patients — Here's How It Works
- Bud Lords

- 7 days ago
- 6 min read
Maryland Cannabis Care Hotline for Medical Patients: The Free Helpline Launching This September
Maryland medical cannabis patients are about to get something most states still don't offer: a free phone line staffed by licensed clinical professionals who can answer real health questions about cannabis. The Maryland Cannabis Administration (MCA) is launching its Cannabis Care Line (CCL) pilot program, with the service expected to go live in September 2026.
This is not a general information line or a chatbot. The Maryland cannabis care hotline for medical patients will connect callers with pharmacists, nurses, or physicians who have documented training in medical cannabis — clinicians who can talk through product selection, side effects, and potential drug interactions without recommending specific brands.
Here is what Maryland patients need to know about who can use it, what it covers, and why the state is building it now.
What Is the Maryland Cannabis Care Line?
The Cannabis Care Line is a free, statewide telephone service developed by the MCA to provide clinical guidance to Marylanders who use cannabis. The program was designed to fill a gap: most patients get their product information from a budtender at the dispensary counter, not from a healthcare provider with training in drug interactions and pharmacology.
The MCA released a formal Request for Proposals (RFP) for the program on June 24, 2026, with a proposal deadline of July 16, 2026. As of early August 2026, the contract award process is in its final stages. The selected contractor will operate the line on a nine-month pilot base period running from September 2026 through May 2027, with an option to extend through 2028.
The contract is capped at $200,000 for the pilot duration — a targeted investment relative to the clinical gap it addresses. According to MCA procurement documents, the selected vendor will integrate with the state's existing Lumen/Genesys call center infrastructure, allowing the agency to track call volume, common patient questions, and outcomes data to decide whether to scale the program permanently.
Who Can Call the Maryland Cannabis Care Hotline?
The Cannabis Care Line is primarily designed for registered medical cannabis patients, but adult-use consumers will also be allowed to use the service for clinical questions.
That is a meaningful distinction. Maryland's adult-use market launched in July 2023, and since then the medical patient registry has contracted significantly. According to MCA data, the program peaked at over 163,000 certified patients in mid-2023 and declined to approximately 86,700 by November 2025 — a drop of roughly 38.5%. Many lower-volume consumers concluded that the cost and paperwork of maintaining a medical card outweighed the benefits once recreational products became widely available.
The MCA's decision to open the care line to both patient groups signals a broader public health approach: clinical support should be available to any Marylander using cannabis, not just those who have paid the roughly $250 annual cost of maintaining a medical registration.
Note: The care line provides general clinical guidance only. It is not a substitute for individualized medical advice. Patients with specific health conditions, prescription medications, or concerns about their cannabis use should always consult a licensed healthcare provider.
What Kind of Help Will the Care Line Provide?
The Cannabis Care Line is designed to address the clinical questions that dispensary staff cannot answer and that many certifying providers do not have time to address in a brief appointment. According to MCA program documents, the service will cover:
Product selection guidance — helping patients understand which product types or consumption methods may be appropriate for their qualifying conditions, without endorsing specific brands or manufacturers
Side effect management — answering questions about common adverse effects and when a patient should contact their own healthcare provider
Drug interaction screening — flagging potential contraindications between cannabis and other medications a patient may be taking
Cannabis use disorder screening and referrals — connecting callers to appropriate resources if their patterns of use raise health concerns
The line will be staffed by licensed healthcare professionals — pharmacists, registered nurses, physicians, or physician assistants — who have documented specialized training in medical cannabis. Staff are explicitly prohibited from recommending specific product brands or manufacturers.
All health-related guidance from the care line is general information only. It does not constitute individualized medical advice. Patients should always discuss their specific health circumstances with their own qualified healthcare provider.
When Will the Maryland Cannabis Care Hotline Launch?
The pilot is expected to launch in September 2026. The MCA anticipated roughly four to six weeks between contract award and the service going live, and the agency entered the evaluation phase following the July 16 proposal deadline.
Hours of operation are subject to the final contract, but MCA procurement documents specified a minimum of 12 hours of weekly live coverage, with scheduling weighted toward peak dispensary shopping periods: Wednesday through Friday afternoons and Saturday midday.
As of August 7, 2026, the contractor name has not been publicly announced. The MCA typically releases a press release with contractor details shortly before a program's public launch. The contract was designated as a Small Business Reserve (SBR) procurement, meaning only certified Maryland small businesses were eligible to submit proposals.
Why the MCA Built This Program
The Cannabis Care Line emerged directly from patient feedback. The MCA's 2025 Maryland Medical Cannabis Patient Survey found that more than 80% of respondents expressed interest in a free clinical helpline — making it one of the most requested patient support improvements in the survey's history.
The survey also documented a widening gap in clinical support. As dispensaries converted to dual-use operations after 2023, medical patients increasingly reported difficulty getting health-specific guidance from the providers who certified them. Certifying appointments are often brief, and dispensary staff — while knowledgeable — are not clinicians. Patients managing complex medication regimens, chronic conditions, or new to cannabis reported feeling underserved by both.
The program reflects a broader MCA strategy to strengthen the value of the medical cannabis program at a time when registry enrollment is declining. The patients who stay registered are disproportionately those with serious qualifying conditions who depend on cannabis as part of a managed care routine — exactly the patients who most need clinical support, and who have the most to lose from a drug interaction they didn't know to ask about.
How This Fits Maryland's Cannabis Health Framework
Maryland's approach to cannabis regulation has included a consistent public health component since legalization. The MCA's BeCannabisSmart public education campaign, launched alongside adult-use sales in 2023, covers responsible use, youth prevention, and impaired driving. The Cannabis Care Line extends that framework into direct clinical services for people already using cannabis.
The MCA has also focused on the Compassionate Use Fund (CUF), which provides financial assistance for low-income patients who struggle to afford medical cannabis products. The 2025 patient survey found a sharp income gradient in affordability: patients earning under $30,000 reported significant difficulty covering costs, even for qualifying patients with tax-exempt medical purchases.
The care line does not solve affordability directly, but it does address a different kind of access problem. For patients already using cannabis, having a licensed professional to call before changing products, adjusting consumption, or managing a new medication interaction could meaningfully reduce harm. That is a public health win whether or not the patient holds a medical card.
What Maryland Patients Should Do Now
The Cannabis Care Line is not live yet as of this writing in August 2026. Here is what medical cannabis patients in Maryland can do in the meantime:
For administrative questions about registration, card renewals, or address changes, contact the MCA Patient and Caregiver Support line at 1-844-421-2571 or email mca.infoandregistration@maryland.gov. Walk-in support is available Monday through Friday, 10 a.m. to 2 p.m. at 849 International Drive, Suite 100, Linthicum, MD 21090.
For general cannabis health questions, speak with your certifying provider or a licensed pharmacist familiar with drug interactions.
Watch the MCA official site at cannabis.maryland.gov for the press release announcing the contractor and launch date for the care line.
When the line goes live, it will be free to call and available to both registered medical patients and adult-use consumers with clinical questions.
Stay Informed with Bud Lords
Maryland is taking meaningful steps to make medical cannabis safer and more accessible for the patients who rely on it most. The Cannabis Care Line is one of the most practical patient-support programs any state has launched — and it's coming to Maryland patients this fall.
For the latest Maryland cannabis news, policy updates, and product guides, visit the Bud Lords Cannabis Newsroom. If you are looking for quality cannabis products available for delivery in Maryland, browse the Bud Lords shop or explore our full product catalog. For edible options — the most popular consumption method among Maryland medical patients per the 2025 survey — check our edibles collection.
Maryland patients deserve both great products and real clinical support. The MCA is working to provide the latter. Visit Bud Lords to shop Maryland-accessible cannabis with same-day delivery.
This article is general information only and does not constitute medical or legal advice. Maryland cannabis laws and program details may change. Consult a licensed healthcare provider for personalized medical guidance regarding cannabis use.
This article was researched and written with AI assistance by the Bud Lords AI Newsroom.




_edited.png)


















Comments